Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Cannabis Use of Minors Imprisoned in the PACA Region

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03659942
Recruitment Status : Not yet recruiting
First Posted : September 6, 2018
Last Update Posted : September 6, 2018
Sponsor:
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille

Brief Summary:

To date, there is little data on the consumption of young adults in detention.

The main objective of this project is to document the prevalence of problematic cannabis use before incarceration among juveniles detained in the various detention centers in the PACA

Secondary objectives are to document:

  • the prevalence of cannabis use over the course of life, last year and last month;
  • the prevalence of harm and risky behavior associated with the use of a psychoactive substance
  • associated addictions and first and foremost tobacco
  • the determinants (socio-demographic, socio-economic, environmental, etc.) of problem use and cannabis use.

This is a multicenter cross-sectional study aimed at establishing an exhaustive picture of the defined population region over a 12-month period.

The holder of the parental authority exercise and the individual agreeing to participate in the study must:

  • sign an informed consent a no objection card
  • complete a car book and hetero-questionnaires. The time of handover is evaluated at 30 minutes.

The CAST questionnaire will be used to answer the main purpose of the study and to identify consumers with problematic cannabis use.

CAST scores will be calculated. Abnormal CAST proportions will be presented along with their 95% confidence intervals. The links between the score and the various variables identified as determinants will be tested using uni and multivariate analyzes.

The assessment of the health status and needs of this extremely vulnerable population is a prerequisite for defining specific regional objectives and for establishing a coherent and coordinated effective health intervention within the community. prisoner in France.


Condition or disease Intervention/treatment
Cannabis Use Other: CAST questionnaire

Detailed Description:

To date, there is little data on the consumption of young adults in detention when they are the first consumers in the general population in France and they represent a particularly vulnerable population within the prison population.

objectives The main objective of this project is to document the prevalence of problematic cannabis use before incarceration among juveniles detained in the various detention centers in the P.A.C.A.

Secondary objectives are to document:

  • the prevalence of cannabis use over the course of life, last year and last month;
  • the prevalence of harm and risky behavior associated with the use of a psychoactive substance
  • associated addictions and first and foremost tobacco
  • the determinants (socio-demographic, socio-economic, environmental, etc.) of problem use and cannabis use.

Method This is a multicenter cross-sectional study aimed at establishing an exhaustive picture of the defined population (juvenile detainees in the P.A.C.A.) region over a 12-month period.

The holder of the parental authority exercise and the individual agreeing to participate in the study must:

  • sign an informed consent a no objection card
  • complete a car book and hetero-questionnaires. The time of handover is evaluated at 30 minutes.

The CAST questionnaire will be used to answer the main purpose of the study and to identify consumers with problematic cannabis use.

CAST scores will be calculated. Abnormal CAST proportions will be presented along with their 95% confidence intervals. The links between the score and the various variables identified as determinants (socio-demographic, socio-economic, environmental, other addictions, etc.) will be tested using uni and multivariate analyzes.

Expected results The assessment of the health status and needs of this extremely vulnerable population is a prerequisite for defining specific regional objectives and for establishing a coherent and coordinated effective health intervention within the community. prisoner in France.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study of the Cannabis Use of Minors Imprisoned in the PACA Region (France)
Estimated Study Start Date : January 2019
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : June 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Marijuana

Group/Cohort Intervention/treatment
Experimental group
New child arriving in detention CAST questionnaire will be performed
Other: CAST questionnaire
the CAST questionnaire will be used to answer the main objective of the study and to identify consumers with problematic cannabis use. This is a validated self-questionnaire in France (Legleye et al., 2011), specific to the adolescent population, which is interpreted according to the score obtained (Bastiani et al., 2013, Legleye et al. 2007, Legleye et al., 2011). It includes 6 items with answer modes coded from 0 to 4. The total score obtained by summing these 6 items can therefore vary from 0 to 24. We define users without risk for a score of less than 3, users with low risk for a score greater than or equal to 3 and less than 7, and finally those with a risk of problematic use for a score greater than or equal to 7




Primary Outcome Measures :
  1. CAST questionnaire score [ Time Frame: 30 minutes ]
    the CAST questionnaire will be used to answer the main objective of the study and to identify consumers with problematic cannabis use. This is a validated self-questionnaire in France (Legleye et al., 2011), specific to the adolescent population, which is interpreted according to the score obtained. It includes 6 items with answer modes coded from 0 to 4. The total score obtained by summing these 6 items can therefore vary from 0 to 24. We define users without risk for a score of less than 3, users with low risk for a score greater than or equal to 3 and less than 7, and finally those with a risk of problematic use for a score greater than or equal to 7



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients new arriving in prison
Criteria

Inclusion Criteria:

  • Newcomer subject in detention,
  • Subject having been informed about the study and not expressing opposition to participating in the study.
  • Legal officer who was informed about the study and did not express any opposition to participate in the study.
  • Subject including French and able to fill self-questionnaires, and not presenting attacks of the severe cognitive functions

Exclusion Criteria:

Subject already incarcerated less than 6 months before its inclusion,

  • subject with severe hearing loss,
  • Subject not having agreed to participate in the study,
  • Holder of parental authority who has not given his consent,
  • Subject not including French.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03659942


Contacts
Layout table for location contacts
Contact: OLIVIER BAGNIS, MD Olivier.BAGNIS@ap-hm.fr

Locations
Layout table for location information
France
Assistance Publique Des Hopitaux de Marseille Not yet recruiting
Marseille, Paca, France, 13354
Contact: OLIVIER BAGNIS, MD       Olivier.BAGNIS@ap-hm.fr   
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Layout table for investigator information
Study Director: EMILIE GARRIDO PRADALIE APHM

Layout table for additonal information
Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT03659942     History of Changes
Other Study ID Numbers: 2017-25
First Posted: September 6, 2018    Key Record Dates
Last Update Posted: September 6, 2018
Last Verified: September 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Marijuana Abuse
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders